Nanjing Pharmaceutical Co (SHSE:600713) Other Operating Expense : ¥1,186 Mil (TTM As of Sep. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Nanjing Pharmaceutical Co Other Operating Expense?

Nanjing Pharmaceutical Co's Other Operating Expense for the three months ended in Sep. 2024 was ¥-457 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1,186 Mil.

Nanjing Pharmaceutical Co's quarterly Other Operating Expense increased from Mar. 2024 (¥19 Mil) to Jun. 2024 (¥502 Mil) but then declined from Jun. 2024 (¥502 Mil) to Sep. 2024 (¥-457 Mil).

Nanjing Pharmaceutical Co's annual Other Operating Expense increased from Dec. 2021 (¥1,051 Mil) to Dec. 2022 (¥1,123 Mil) and increased from Dec. 2022 (¥1,123 Mil) to Dec. 2023 (¥1,164 Mil).

Nanjing Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Nanjing Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Pharmaceutical Co Other Operating Expense Chart

Nanjing Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

997.44

1,030.92

1,050.76

1,123.00

1,163.91

Nanjing Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Operating Expense	Get a 7-Day Free Trial															-473.27	1,121.09	19.39	502.49	-456.62

Nanjing Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,186 Mil.

Nanjing Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Nanjing Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Pharmaceutical Co Ltd (SHSE:600713) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 486 Zhongshan East Road, Nanjing, Jiangsu, CHN, 210002

Website

http://www.guangyuyuan.com

Nanjing Pharmaceutical Co Ltd is engaged in the pharmaceutical service business.

Executives

Xiao Hong	senior management
Peng Yu Ping	senior management
She Ping	Supervisors
Jiang Xiao Jun	senior management
Teng Xue Wu	senior management
Zhou Jian Jun	senior management
Li Yi	Director
Huang Yan Li	Supervisors
Tang Jian Zhong	senior management
Zhang Yan Hui	senior management
Zhou Yao Ping	Director
Wang Hui Qing	senior management
He Jin Geng	senior management
Ding Feng Jun	Director
Liang Yu Tang	Director

Nanjing Pharmaceutical Co Headlines

No Headlines